Boston University & Med-IQ: Live ECHO® Program: Integrating BCMA-Directed Bispecific Antibodies Into the Treatment Algorithm for Multiple Myeloma
This one-hour ECHO® session equips community oncology teams to apply BCMA‑directed bispecific antibodies in real-world multiple myeloma care, manage treatment-related adverse events, and strengthen coordinated multidisciplinary practice through Communities of Practice. This session specifically focuses on appropriately incorporating BCMA-directed BsAbs into clinical practice.
Key Features
Enhance your patient care with our expert-led, case-based Project ECHO CME/CE series. You’ll gain practical tools, valuable peer insights, and actionable strategies to apply the latest scientific advancements in your daily practice.
Topics Covered
BCMA-directed bispecific antibodies for the treatment of multiple myeloma
Learning Objectives
Appropriately incorporate BCMA-directed BsAbs into cases of patients with MM that are representative of clinical practice.
Target Audience
This activity is intended primarily for oncologists and other healthcare professionals responsible for the care and treatment of patients with RRMM.
Additional credit info
This activity is developed as a joint collaboration among Boston University Chobanian & Avedisian School of Medicine, Med-IQ, the AAPA, the Association of PAs in Oncology (APAO), and HealthTree Foundation.
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Accreditation
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine Maintenance of Certification (MOC) Part 2 Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By participating and claiming credit, you agree to BU sharing your information with ACCME PARS the data conduit to the ABIM.
Nurse Accreditation
Nursing Contact Hours: 1.0, of which 1.0 is eligible for pharmacology credit.
Pharmacist Accreditation
This activity is approved for 1.0 CPE credit.
Physician Associate Accreditation
Boston University Chobanian & Avedisian School of Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.